"Glossy drawings and new press releases cannot disguise the reality: this project poses serious risks and still faces a ...

Biohaven › On a very good Friday for the stock market, Biohaven's (NYSE: BHVN) performance was exceptional. The clinical-stage biotech's share price inflated by over 6% that trading session thanks to ...

Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.

Stock futures ticked higher on Friday as investors awaited Federal Reserve Chair Jerome Powell’s speech at Jackson Hole, looking for clues on the outlook for mo ...

Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Biohaven (NYSE:BHVN) stock gains as the FDA cancels an advisory meeting scheduled to review its marketing application for ...

The latest announcement is out from Biohaven Ltd. ( (BHVN) ).

Investing.com -- Biohaven Ltd. (NYSE: BHVN) stock rose 3% Friday morning after the company announced that the U.S. Food and Drug Administration (FDA) no longer plans to hold an advisory committee ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusiv ...